Alexis Nahama, D.V.M.
« Back to Team
SVP - Head of Resiniferatoxin (RTX) Program
- Dr. Nahama leads RTX human and animal health drug development programs
- As a member leadership team, Dr. Nahama supports strategy development, oversees high value projects, facilitates go to market preparation, and nurtures external alliance efforts
- Passionately drives the translational opportunities to accelerate human development programs while bringing technologies that otherwise would not be available to pets
- Prior to joining Sorrento, he spent over 25 years holding global executive roles working in Life Sciences and Biotechnology for Sanofi, Colgate, Novartis, Merck, VCA Antech and VetStem Biopharma
- D.V.M. with early career focused on R&D in the pain area (clinical trials for pets)
